Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
De Novo Sirolimus-based Immunosuppression After Liver Transplantation for Hepatocellular Carcinoma
NCT00328770Phase 3Completed
- Sponsor
- University of Alberta
- Start
- Dec 1996
- Primary completion
- Mar 2006
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nab-sirolimus in hepatocellular carcinoma (HCC), sponsored by University of Alberta. Started Dec 1996; status: completed.
02
Drugs
nab-sirolimus
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00328770.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00328770.